| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |